Main news


Statins may reduce death from, severity of COVID-19 among those with heart disease or high blood pressure Research published today in The Public Library of Science ONE, PLOS ONE, examined the relationship between use of medications to control cholesterol or blood pressure levels, and the risk of death among people who were hospitalized due to COVID-19.



Death disruptor: how an Australian funnel-web spider may help human hearts A protein in the venom of a deadly Australian funnel-web spider may be able to reduce cardiac damage from heart attacks and extend the life of donor hearts used in transplants, according to new research.



Comorbidities and COVID: A much higher risk of death While some countries are vaccinating their way out of the COVID-19 pandemic and are starting to see an easing of restrictions, other countries in South Asia are experiencing a new wave of infections that are causing devastation to their populations and healthcare systems.



Fruit and Vegetable Intake and Mortality Results From 2 Prospective Cohort Studies of US Men and Women and a Meta-Analysis of 26 Cohort Studies



Heart patients three times more likely to have diabetes than general population Nearly 30% of patients with coronary artery disease have diabetes, according to a large study published on World Health Day in the European Journal of Preventive Cardiology, a journal of the European Society of Cardiology (ESC).1 That compares to a diabetes prevalence of around 9% in the general population.2 There was wide geographical variation, with 60% of heart disease patients in Gulf countries having diabetes compared to 20% in Europe.



People with severe gum disease may be twice as likely to have increased blood pressure Adults with periodontitis, a severe gum infection, may be significantly more likely to have higher blood pressure compared to individuals who had healthy gums, according to new research published today in Hypertension, an American Heart Association journal.



Instant death from heart attack more common in people who do not exercise Heart disease is the leading cause of death globally and prevention is a major public health priority. The beneficial impact of physical activity in stopping heart disease and sudden death on a population level is well documented. This study focused on the effect of an active versus sedentary lifestyle on the immediate course of a heart attack – an area with little information.



Left atrial appendage closure versus medical therapy in patients with atrial fibrillation: the APPLY study Left atrial appendage closure (LAAC) with AMPLATZER occluders is used for stroke prevention in atrial fibrillation (AF). Net clinical benefit compared to medical therapy has not been tested. The aim of this study was to test whether long-term clinical outcome after LAAC with AMPLATZER occluders may be similar to medical therapy.



Cell Therapy for Anthracycline-Induced Cardiomyopathy Safe, Feasible Fran Lowry In yet another trial of cell therapy for heart failure, this time in cancer survivors with anthracycline-induced cardiomyopathy (AIC), administration of allogeneic bone marrow-derived mesenchymal stromal cells (allo-MSCs) was shown to be safe and feasible.



Randomized Trial of Transfusion Strategies in Patients With Myocardial Infarction and Anemia - REALITY The REALITY trial showed that a restrictive PRBC transfusion strategy (transfusion for Hgb ≤8 g/dl, goal Hgb 8-10 g/dl) is noninferior to a more liberal strategy (transfusion for Hgb ≤10 g/dl, goal Hgb >11 g/dl).


AHA Scientific Sessions 2020 and the Resuscitation Science Symposium 2020!
AHA Scientific Sessions 2020 and the Resuscitation Science Symposium 2020! Welcome to AHA Scientific Sessions 2020 and the Resuscitation Science Symposium (RESS) 2020!


World Heart Day 2021
World Heart Day 2021 World Heart Day is a global health campaign. Its main task is to raise awareness about diseases of the cardiovascular system, the reasons for their occurrence and how to prevent them. For the first time, cardiologists at an international congress in 2012 announced the need to establish a holiday. Then, in the presence of world leaders, shocking numbers were announced. More than 18 million people die from cardiovascular diseases worldwide every year.


Editorial Activity

cardiology book

What's New in the AHA/ASA Secondary Stroke Prevention Guidelines?
What's New in the AHA/ASA Secondary Stroke Prevention Guidelines? Clinical Context Risk for recurrent stroke or TIA is high but can be lowered by appropriate secondary stroke prevention. As secondary stroke prevention strategies have improved in recent years, cohort studies have shown decreased rates of recurrent stroke and transient ischemic attack (TIA).


ESC Congress 2021
ESC Congress 2021 ESC Congress is first and foremost a celebration of science. It's all about challenging and inspiring cardiovascular professionals to discover and deliver the best care possible to their patients. It’s widely regarded as THE annual cardiology event in the calendar.


Peripheral arterial disease - indications for intervention: from open surgery to endovascular and hybrid repair
Peripheral arterial disease - indications for intervention: from open surgery to endovascular and hybrid repair Peripheral arterial disease (PAD) is a marker of increased risk of СV mortality and limb loss. Staging of limb ischaemia severity, assessment of patient risk and knowledge of PAD anatomy are essential requirements to improve survival, reduce major cardiovascular events and to treat the ischaemic syndrome.


New Clinical Practice Guideline for the Management of Adult Overweight and Obesity
New Clinical Practice Guideline for the Management of Adult Overweight and Obesity Synopsis summarizes the key recommendations of the guideline regarding management of overweight and obesity, including referral to comprehensive lifestyle interventions that combine behavioral, dietary, and physical activity change, and additional tools of pharmacologic and procedural interventions.


HFA CONFERENCE NEWS June 29 - July 01, 2021, Virtual
HFA CONFERENCE NEWS June 29 - July 01, 2021, Virtual IV Iron Can Save Costs in HF With Iron Deficiency in Analysis; HF Med Undertreatment Due to Older Age Common, Flouts Evidence; Iron-Clad Benefits of CRT Seen in Reduced-EF Heart Failure; Assays May Guide SGLT2 Inhibitor Use in High CV-Risk Diabetes



"COVID-19 and cardiovascular diseases: main aspects" The report of Igor S. Yavelov MD, PhD, Professor of cardiology CV risk factors and CVD are present in many patients with COVID-19 and their presence is associated with an increased risk of cardiovascular complications with new coronavirus infection.


Young adults who lost and then restored heart health had lower risk of heart attack, stroke
Young adults who lost and then restored heart health had lower risk of heart attack, stroke A long-term analysis of young adults in Korea found that those with poor heart health had higher rates of cardiovascular disease at a younger age.


EAS Helsinki 2021 Virtual.  THE RISE OF CARDIOMETABOLIC DISEASE
EAS Helsinki 2021 Virtual. THE RISE OF CARDIOMETABOLIC DISEASE Not only are we living in a COVID-19 pandemic, but also an accelerating pandemic of cardiometabolic disease, requiring renewed focus. The third plenary session discussed options to address this escalation in cardiometabolic disease.